A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

Trial Profile

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 13 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 Dec 2013 Last checked against Korean Clinical Trials Register record.
    • 13 Feb 2013 Planned end date changed from 1 Aug 2013 to 2 Sep 2013 as reported by Korean Clinical Trials Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top